Three months ended | ||||||||||||||||||||||||||||||||
(in millions, except per-share data) | 6/30/2023 | 6/30/2022 | Change | 3/31/2023 | Change | |||||||||||||||||||||||||||
U.S. GAAP basis | ||||||||||||||||||||||||||||||||
Investment advisory fees | $ | 1,430.8 | $ | 1,496.7 | (4.4) | % | $ | 1,391.8 | 2.8 | % | ||||||||||||||||||||||
Capital allocation-based income(1) (2) | $ | 38.7 | $ | (126.3) | n/m | $ | 16.9 | n/m | ||||||||||||||||||||||||
Net revenues | $ | 1,610.2 | $ | 1,513.0 | 6.4 | % | $ | 1,537.6 | 4.7 | % | ||||||||||||||||||||||
Operating expenses | $ | 1,076.7 | $ | 844.4 | 27.5 | % | $ | 1,053.4 | 2.2 | % | ||||||||||||||||||||||
Net operating income | $ | 533.5 | $ | 668.6 | (20.2) | % | $ | 484.2 | 10.2 | % | ||||||||||||||||||||||
Non-operating income (loss)(2) | $ | 106.2 | $ | (279.9) | n/m | $ | 135.4 | n/m | ||||||||||||||||||||||||
Net income attributable to T. Rowe Price | $ | 476.4 | $ | 339.6 | 40.3 | % | $ | 421.5 | 13.0 | % | ||||||||||||||||||||||
Diluted earnings per common share | $ | 2.06 | $ | 1.46 | 41.1 | % | $ | 1.83 | 12.6 | % | ||||||||||||||||||||||
Weighted average common shares outstanding assuming dilution | 225.2 | 227.9 | (1.2) | % | 225.2 | — | % | |||||||||||||||||||||||||
Adjusted basis(3) | ||||||||||||||||||||||||||||||||
Operating expenses | $ | 1,026.2 | $ | 947.3 | 8.3 | % | $ | 1,022.5 | 0.4 | % | ||||||||||||||||||||||
Operating expenses, excluding accrued carried interest compensation | $ | 1,010.5 | $ | 992.5 | 1.8 | % | $ | 1,013.9 | (0.3) | % | ||||||||||||||||||||||
Net operating income | $ | 596.6 | $ | 579.7 | 2.9 | % | $ | 528.0 | 13.0 | % | ||||||||||||||||||||||
Non-operating income (loss)(2) | $ | 31.8 | $ | (30.6) | n/m | $ | 30.8 | n/m | ||||||||||||||||||||||||
Net income attributable to T. Rowe Price | $ | 466.5 | $ | 417.7 | 11.7 | % | $ | 389.4 | 19.8 | % | ||||||||||||||||||||||
Diluted earnings per common share | $ | 2.02 | $ | 1.79 | 12.8 | % | $ | 1.69 | 19.5 | % | ||||||||||||||||||||||
Assets under management (in billions) | ||||||||||||||||||||||||||||||||
Average assets under management | $ | 1,357.4 | $ | 1,407.1 | (3.5) | % | $ | 1,322.9 | 2.6 | % | ||||||||||||||||||||||
Ending assets under management | $ | 1,399.4 | $ | 1,309.7 | 6.8 | % | $ | 1,341.7 | 4.3 | % | ||||||||||||||||||||||
Investment advisory effective fee rate (bps) | 42.3 | 42.7 | (0.9) | % | 42.7 | (0.9) | % |
Three months ended 6/30/2023 | |||||||||||||||||||||||||||||
(in billions) | Equity | Fixed income, including money market | Multi-asset(1) | Alternatives(2) | Total | ||||||||||||||||||||||||
Assets under management at beginning of period | $ | 695.1 | $ | 170.4 | $ | 431.9 | $ | 44.3 | $ | 1,341.7 | |||||||||||||||||||
Net cash flows(3) | (19.5) | (1.9) | 1.6 | (0.2) | (20.0) | ||||||||||||||||||||||||
Net market appreciation and gains(4) | 56.6 | 0.8 | 19.7 | 0.6 | 77.7 | ||||||||||||||||||||||||
Change during the period | 37.1 | (1.1) | 21.3 | 0.4 | 57.7 | ||||||||||||||||||||||||
Assets under management at June 30, 2023 | $ | 732.2 | $ | 169.3 | $ | 453.2 | $ | 44.7 | $ | 1,399.4 |
Three months ended | ||||||||||||||||||||||||||||||||
(in millions) | 6/30/2023 | 6/30/2022 | % Change | 3/31/2023 | % Change | |||||||||||||||||||||||||||
Investment advisory fees | ||||||||||||||||||||||||||||||||
Equity | $ | 862.3 | $ | 941.0 | (8.4) | % | $ | 833.9 | 3.4 | % | ||||||||||||||||||||||
Fixed income, including money market | 100.0 | 109.9 | (9.0) | % | 102.4 | (2.3) | % | |||||||||||||||||||||||||
Multi-asset | 391.3 | 377.5 | 3.7 | % | 386.0 | 1.4 | % | |||||||||||||||||||||||||
Alternatives | 77.2 | 68.3 | 13.0 | % | 69.5 | 11.1 | % | |||||||||||||||||||||||||
Total investment advisory fees | $ | 1,430.8 | $ | 1,496.7 | (4.4) | % | $ | 1,391.8 | 2.8 | % | ||||||||||||||||||||||
Capital allocation-based income(1) | $ | 38.7 | $ | (126.3) | n/m | $ | 16.9 | n/m | ||||||||||||||||||||||||
Administrative, distribution, and servicing fees | 140.7 | 142.6 | (1.3) | % | 128.9 | 9.2 | % | |||||||||||||||||||||||||
Net revenues | $ | 1,610.2 | $ | 1,513.0 | 6.4 | % | $ | 1,537.6 | 4.7 | % | ||||||||||||||||||||||
Average AUM (in billions): | ||||||||||||||||||||||||||||||||
Equity | $ | 703.4 | $ | 769.6 | (8.6) | % | $ | 687.0 | 2.4 | % | ||||||||||||||||||||||
Fixed income, including money market | 170.4 | 174.8 | (2.5) | % | 169.6 | 0.5 | % | |||||||||||||||||||||||||
Multi-asset | 439.0 | 420.2 | 4.5 | % | 422.2 | 4.0 | % | |||||||||||||||||||||||||
Alternatives | 44.6 | 42.5 | 4.9 | % | 44.1 | 1.1 | % | |||||||||||||||||||||||||
Average AUM | $ | 1,357.4 | $ | 1,407.1 | (3.5) | % | $ | 1,322.9 | 2.6 | % | ||||||||||||||||||||||
Three months ended | ||||||||||||||||||||||||||||||||
(in millions) | 6/30/2023 | 6/30/2022 | % Change | 3/31/2023 | % Change | |||||||||||||||||||||||||||
Compensation, benefits, and related costs | $ | 591.0 | $ | 589.8 | 0.2 | % | $ | 593.3 | (0.4) | % | ||||||||||||||||||||||
Acquisition-related retention agreements | 13.6 | 18.0 | (24.4) | % | 14.2 | (4.2) | % | |||||||||||||||||||||||||
Capital allocation-based income compensation(1) | 10.6 | (50.9) | n/m | 3.5 | n/m | |||||||||||||||||||||||||||
Supplemental savings plan(1) | 33.0 | (93.5) | n/m | 42.5 | n/m | |||||||||||||||||||||||||||
Total compensation and related costs | 648.2 | 463.4 | 39.9 | % | 653.5 | (0.8) | % | |||||||||||||||||||||||||
Distribution and servicing | 67.8 | 75.7 | (10.4) | % | 71.5 | (5.2) | % | |||||||||||||||||||||||||
Advertising and promotion | 22.9 | 21.4 | 7.0 | % | 25.8 | (11.2) | % | |||||||||||||||||||||||||
Product and recordkeeping related costs | 77.7 | 76.3 | 1.8 | % | 72.1 | 7.8 | % | |||||||||||||||||||||||||
Technology, occupancy, and facility costs | 154.7 | 134.3 | 15.2 | % | 146.6 | 5.5 | % | |||||||||||||||||||||||||
General, administrative, and other | 100.0 | 96.4 | 3.7 | % | 107.5 | (7.0) | % | |||||||||||||||||||||||||
Change in fair value of contingent consideration | (23.2) | (50.3) | (53.9) | % | (49.6) | (53.2) | % | |||||||||||||||||||||||||
Acquisition-related amortization and impairment costs | 28.6 | 27.2 | 5.1 | % | 26.0 | 10.0 | % | |||||||||||||||||||||||||
Total operating expenses | $ | 1,076.7 | $ | 844.4 | 27.5 | % | $ | 1,053.4 | 2.2 | % | ||||||||||||||||||||||
Total adjusted operating expenses(2) | $ | 1,026.2 | $ | 947.3 | 8.3 | % | $ | 1,022.5 | 0.4 | % |
(in millions) | Three months ended | ||||||||||||||||
6/30/2023 | 6/30/2022 | 3/31/2023 | |||||||||||||||
Net gains (losses) from non-consolidated T. Rowe Price investment products | |||||||||||||||||
Cash and discretionary investments | |||||||||||||||||
Dividend income | $ | 25.5 | $ | 2.8 | $ | 20.2 | |||||||||||
Market-related gains (losses) and equity in earnings (losses) | 6.3 | (33.4) | 10.6 | ||||||||||||||
Total net gains (losses) from cash and discretionary investments | 31.8 | (30.6) | 30.8 | ||||||||||||||
Seed capital investments | |||||||||||||||||
Dividend income | 0.4 | 0.2 | 0.5 | ||||||||||||||
Market-related gains (losses) and equity in earnings (losses) | 14.4 | (40.6) | 15.1 | ||||||||||||||
Net gains recognized upon deconsolidation | — | 5.2 | — | ||||||||||||||
Investments used to hedge the supplemental savings plan liability | 33.6 | (96.4) | 44.7 | ||||||||||||||
Total net gains (losses) from non-consolidated T. Rowe Price investment products | 80.2 | (162.2) | 91.1 | ||||||||||||||
Other investment income (loss) | 8.9 | (7.7) | 2.8 | ||||||||||||||
Net gains (losses) on investments | 89.1 | (169.9) | 93.9 | ||||||||||||||
Net gains (losses) on consolidated sponsored investment portfolios | 24.4 | (104.6) | 45.4 | ||||||||||||||
Other losses, including foreign currency losses | (7.3) | (5.4) | (3.9) | ||||||||||||||
Non-operating income (loss) | $ | 106.2 | $ | (279.9) | $ | 135.4 | |||||||||||
Three months ended | Six months ended | |||||||||||||||||||||||||
6/30/2023 | 6/30/2022 | 6/30/2023 | 6/30/2022 | |||||||||||||||||||||||
Statutory U.S. federal income tax rate | 21.0 | % | 21.0 | % | 21.0 | % | 21.0 | % | ||||||||||||||||||
State income taxes for current year, net of federal income tax benefits(1) | 2.8 | 3.9 | 2.9 | 3.5 | ||||||||||||||||||||||
Net (income) losses attributable to redeemable non-controlling interests(2) | (0.3) | 2.7 | (0.3) | 1.1 | ||||||||||||||||||||||
Net excess tax benefits from stock-based compensation plans activity | (0.2) | (0.5) | (0.3) | (0.5) | ||||||||||||||||||||||
Other items, including valuation allowances | 1.5 | (1.1) | 3.4 | (0.2) | ||||||||||||||||||||||
Effective income tax rate | 24.8 | % | 26.0 | % | 26.7 | % | 24.9 | % | ||||||||||||||||||
Public Relations | Investor Relations | ||||||||||
Jeanne Moore | Linsley Carruth | ||||||||||
443-938-0463 | 410-345-3717 | ||||||||||
jeanne.moore@troweprice.com | linsley.carruth@troweprice.com | ||||||||||
Unaudited Consolidated Statements of Income | |||||||||||||||||||||||||||||||||||
(in millions, except per-share amounts) | |||||||||||||||||||||||||||||||||||
Three months ended | Six months ended | ||||||||||||||||||||||||||||||||||
Revenues | 6/30/2023 | 6/30/2022 | 3/31/2023 | 6/30/2023 | 6/30/2022 | ||||||||||||||||||||||||||||||
Investment advisory fees | $ | 1,430.8 | $ | 1,496.7 | $ | 1,391.8 | $ | 2,822.6 | $ | 3,158.8 | |||||||||||||||||||||||||
Capital allocation-based income | 38.7 | (126.3) | 16.9 | 55.6 | (81.9) | ||||||||||||||||||||||||||||||
Administrative, distribution, and servicing fees | 140.7 | 142.6 | 128.9 | 269.6 | 299.1 | ||||||||||||||||||||||||||||||
Net revenues | 1,610.2 | 1,513.0 | 1,537.6 | 3,147.8 | 3,376.0 | ||||||||||||||||||||||||||||||
Operating expenses | |||||||||||||||||||||||||||||||||||
Compensation, benefits, and related costs | 591.0 | 589.8 | 593.3 | 1,184.3 | 1,185.7 | ||||||||||||||||||||||||||||||
Acquisition-related retention agreements | 13.6 | 18.0 | 14.2 | 27.8 | 37.2 | ||||||||||||||||||||||||||||||
Capital allocation-based income compensation | 10.6 | (50.9) | 3.5 | 14.1 | (33.4) | ||||||||||||||||||||||||||||||
Supplemental savings plan | 33.0 | (93.5) | 42.5 | 75.5 | (144.5) | ||||||||||||||||||||||||||||||
Total compensation and related costs | 648.2 | 463.4 | 653.5 | 1,301.7 | 1,045.0 | ||||||||||||||||||||||||||||||
Distribution and servicing | 67.8 | 75.7 | 71.5 | 139.3 | 161.6 | ||||||||||||||||||||||||||||||
Advertising and promotion | 22.9 | 21.4 | 25.8 | 48.7 | 44.8 | ||||||||||||||||||||||||||||||
Product and recordkeeping related costs | 77.7 | 76.3 | 72.1 | 149.8 | 156.7 | ||||||||||||||||||||||||||||||
Technology, occupancy, and facility costs | 154.7 | 134.3 | 146.6 | 301.3 | 268.2 | ||||||||||||||||||||||||||||||
General, administrative, and other | 100.0 | 96.4 | 107.5 | 207.5 | 195.2 | ||||||||||||||||||||||||||||||
Contingent consideration fair value adjustments | (23.2) | (50.3) | (49.6) | (72.8) | (95.8) | ||||||||||||||||||||||||||||||
Acquisition-related amortization and impairment costs | 28.6 | 27.2 | 26.0 | 54.6 | 54.3 | ||||||||||||||||||||||||||||||
Total operating expenses | 1,076.7 | 844.4 | 1,053.4 | 2,130.1 | 1,830.0 | ||||||||||||||||||||||||||||||
Net operating income | 533.5 | 668.6 | 484.2 | 1,017.7 | 1,546.0 | ||||||||||||||||||||||||||||||
Non-operating income (loss) | |||||||||||||||||||||||||||||||||||
Net gains (losses) on investments | 89.1 | (169.9) | 93.9 | 183.0 | (259.8) | ||||||||||||||||||||||||||||||
Net gains (losses) on consolidated investment products | 24.4 | (104.6) | 45.4 | 69.8 | (206.0) | ||||||||||||||||||||||||||||||
Other losses | (7.3) | (5.4) | (3.9) | (11.2) | (12.6) | ||||||||||||||||||||||||||||||
Total non-operating income (loss) | 106.2 | (279.9) | 135.4 | 241.6 | (478.4) | ||||||||||||||||||||||||||||||
Income before income taxes | 639.7 | 388.7 | 619.6 | 1,259.3 | 1,067.6 | ||||||||||||||||||||||||||||||
Provision for income taxes | 158.5 | 100.9 | 177.9 | 336.4 | 265.4 | ||||||||||||||||||||||||||||||
Net income | 481.2 | 287.8 | 441.7 | 922.9 | 802.2 | ||||||||||||||||||||||||||||||
Less: net income (loss) attributable to redeemable non-controlling interests | 4.8 | (51.8) | 20.2 | 25.0 | (105.3) | ||||||||||||||||||||||||||||||
Net income attributable to T. Rowe Price | 476.4 | 339.6 | 421.5 | 897.9 | 907.5 | ||||||||||||||||||||||||||||||
Less: net income allocated to outstanding restricted stock and stock unit holders | 11.6 | 7.4 | 10.5 | 22.1 | 20.4 | ||||||||||||||||||||||||||||||
Net income allocated to T. Rowe Price common stockholders | $ | 464.8 | $ | 332.2 | $ | 411.0 | $ | 875.8 | $ | 887.1 | |||||||||||||||||||||||||
Earnings per share | |||||||||||||||||||||||||||||||||||
Basic | $ | 2.07 | $ | 1.47 | $ | 1.83 | $ | 3.90 | $ | 3.90 | |||||||||||||||||||||||||
Diluted | $ | 2.06 | $ | 1.46 | $ | 1.83 | $ | 3.89 | $ | 3.88 | |||||||||||||||||||||||||
Weighted-average common shares | |||||||||||||||||||||||||||||||||||
Outstanding | 224.4 | 226.7 | 224.4 | 224.4 | 227.5 | ||||||||||||||||||||||||||||||
Outstanding assuming dilution | 225.2 | 227.9 | 225.2 | 225.2 | 228.8 | ||||||||||||||||||||||||||||||
Summary of Adjusted Basis(1) | Three months ended | Six months ended | |||||||||||||||||||||||||||||||||
(in millions, except per-share data) | 6/30/2023 | 6/30/2022 | 3/31/2023 | 6/30/2023 | 6/30/2022 | ||||||||||||||||||||||||||||||
Operating expenses | $ | 1,026.2 | $ | 947.3 | $ | 1,022.5 | $ | 2,048.7 | $ | 1,986.4 | |||||||||||||||||||||||||
Operating expenses, excluding accrued carried interest compensation | $ | 1,010.5 | $ | 992.5 | $ | 1,013.9 | $ | 2,024.4 | $ | 2,008.5 | |||||||||||||||||||||||||
Net operating income | $ | 596.6 | $ | 579.7 | $ | 528.0 | $ | 1,124.6 | $ | 1,417.7 | |||||||||||||||||||||||||
Non-operating income (loss) | $ | 31.8 | $ | (30.6) | $ | 30.8 | $ | 62.6 | $ | (54.4) | |||||||||||||||||||||||||
Net income attributable to T. Rowe Price | $ | 466.5 | $ | 417.7 | $ | 389.4 | $ | 855.9 | $ | 1,034.6 | |||||||||||||||||||||||||
Diluted earnings per common share | $ | 2.02 | $ | 1.79 | $ | 1.69 | $ | 3.71 | $ | 4.42 | |||||||||||||||||||||||||
(1) See the reconciliation to the comparable U.S. GAAP measures at the end of this earnings release. |
Assets Under Management | Six months ended 6/30/2023 | ||||||||||||||||||||||||||||
(in billions) | Equity | Fixed income, including money market | Multi-asset(1) | Alternatives(2) | Total | ||||||||||||||||||||||||
Assets under management at beginning of period | $ | 664.2 | $ | 167.0 | $ | 400.1 | $ | 43.4 | $ | 1,274.7 | |||||||||||||||||||
Net cash flows(3) | (43.0) | (1.8) | 8.7 | — | (36.1) | ||||||||||||||||||||||||
Net market appreciation and gains(4) | 111.0 | 4.1 | 44.4 | 1.3 | 160.8 | ||||||||||||||||||||||||
Change during the period | 68.0 | 2.3 | 53.1 | 1.3 | 124.7 | ||||||||||||||||||||||||
Assets under management at June 30, 2023 | $ | 732.2 | $ | 169.3 | $ | 453.2 | $ | 44.7 | $ | 1,399.4 |
Net Revenues | Six months ended | ||||||||||||||||
(in millions) | 6/30/2023 | 6/30/2022 | % Change | ||||||||||||||
Investment advisory fees | |||||||||||||||||
Equity | $ | 1,696.2 | $ | 2,027.0 | (16.3) | % | |||||||||||
Fixed income, including money market | 202.4 | 216.5 | (6.5) | % | |||||||||||||
Multi-asset | 777.3 | 782.1 | (0.6) | % | |||||||||||||
Alternatives | 146.7 | 133.2 | 10.1 | % | |||||||||||||
Total investment advisory fees | $ | 2,822.6 | $ | 3,158.8 | (10.6) | % | |||||||||||
Capital allocation-based income | 55.6 | (81.9) | 167.9 | % | |||||||||||||
Administrative, distribution, and servicing fees | 269.6 | 299.1 | (9.9) | % | |||||||||||||
Net revenues | $ | 3,147.8 | $ | 3,376.0 | (6.8) | % | |||||||||||
Average AUM (in billions): | |||||||||||||||||
Equity | $ | 695.2 | $ | 827.7 | (16.0) | % | |||||||||||
Fixed income, including money market | 170.0 | 176.3 | (3.6) | % | |||||||||||||
Multi-asset | 430.7 | 436.9 | (1.4) | % | |||||||||||||
Alternatives | 44.3 | 42.1 | 5.2 | % | |||||||||||||
Average AUM | $ | 1,340.2 | $ | 1,483.0 | (9.6) | % | |||||||||||
Non-Operating Income (Loss) | |||||||||||
(in millions) | Six months ended | ||||||||||
6/30/2023 | 6/30/2022 | ||||||||||
Net gains (losses) from non-consolidated T. Rowe Price investment products | |||||||||||
Cash and discretionary investments | |||||||||||
Dividend income | $ | 45.7 | $ | 3.6 | |||||||
Market-related gains (losses) and equity in earnings (losses) | 16.9 | (58.0) | |||||||||
Total net gains (losses) from cash and discretionary investments | 62.6 | (54.4) | |||||||||
Seed capital investments | |||||||||||
Dividend income | 0.9 | 0.4 | |||||||||
Market-related gains (losses) and equity in earnings (losses) | 29.5 | (63.4) | |||||||||
Net gains recognized upon deconsolidation | — | 6.8 | |||||||||
Investments used to hedge the supplemental savings plan liability | 78.3 | (151.7) | |||||||||
Total net gains (losses) from non-consolidated T. Rowe Price investment products | 171.3 | (262.3) | |||||||||
Other investment income | 11.7 | 2.5 | |||||||||
Net gains (losses) on investments | 183.0 | (259.8) | |||||||||
Net gains (losses) on consolidated sponsored investment portfolios | 69.8 | (206.0) | |||||||||
Other losses, including foreign currency losses | (11.2) | (12.6) | |||||||||
Non-operating income (loss) | $ | 241.6 | $ | (478.4) | |||||||
Six months ended | |||||||||||||||||||||||
6/30/2023 | |||||||||||||||||||||||
(in millions) | Cash flow attributable to T. Rowe Price | Cash flow attributable to consolidated T. Rowe Price investment products | Elims | As reported | |||||||||||||||||||
Cash flows from operating activities | |||||||||||||||||||||||
Net income (loss) | $ | 897.9 | $ | 62.4 | $ | (37.4) | $ | 922.9 | |||||||||||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities | |||||||||||||||||||||||
Depreciation, amortization and impairments of property, equipment and software | 117.9 | — | — | 117.9 | |||||||||||||||||||
Amortization and impairment of acquisition-related assets and retention agreements | 97.9 | — | — | 97.9 | |||||||||||||||||||
Fair value remeasurement of contingent liability | (72.8) | — | — | (72.8) | |||||||||||||||||||
Stock-based compensation expense | 115.4 | — | — | 115.4 | |||||||||||||||||||
Net (gains) losses recognized on investments | (253.0) | — | 37.4 | (215.6) | |||||||||||||||||||
Net redemptions in sponsored investment products used to economically hedge supplemental savings plan liability | 18.4 | — | — | 18.4 | |||||||||||||||||||
Net change in trading securities held by consolidated sponsored investment products | — | (414.5) | — | (414.5) | |||||||||||||||||||
Other changes | 339.3 | 1.4 | (3.8) | 336.9 | |||||||||||||||||||
Net cash provided by (used in) operating activities | 1,261.0 | (350.7) | (3.8) | 906.5 | |||||||||||||||||||
Net cash provided by (used in) investing activities | (163.5) | (17.8) | 45.4 | (135.9) | |||||||||||||||||||
Net cash provided by (used in) financing activities | (603.4) | 325.0 | (41.6) | (320.0) | |||||||||||||||||||
Effect of exchange rate changes on cash and cash equivalents of consolidated sponsored investment products | — | 0.9 | — | 0.9 | |||||||||||||||||||
Net change in cash and cash equivalents during period | 494.1 | (42.6) | — | 451.5 | |||||||||||||||||||
Cash and cash equivalents at beginning of year | 1,755.6 | 119.1 | — | 1,874.7 | |||||||||||||||||||
Cash and cash equivalents at end of period | $ | 2,249.7 | $ | 76.5 | $ | — | $ | 2,326.2 |
Unaudited Condensed Consolidated Balance Sheet Information (in millions) | As of | ||||||||||
6/30/2023 | 12/31/2022 | ||||||||||
Cash and cash equivalents | $ | 2,249.7 | $ | 1,755.6 | |||||||
Accounts receivable and accrued revenue | 761.4 | 748.7 | |||||||||
Investments | 2,718.4 | 2,539.2 | |||||||||
Assets of consolidated sponsored investment products | 1,946.1 | 1,603.4 | |||||||||
Operating lease assets | 261.6 | 279.4 | |||||||||
Property, equipment and software, net | 771.2 | 755.7 | |||||||||
Goodwill and intangible assets | 3,220.2 | 3,272.6 | |||||||||
Other assets | 692.8 | 688.7 | |||||||||
Total assets | 12,621.4 | 11,643.3 | |||||||||
Supplemental savings plan liability | 817.3 | 761.2 | |||||||||
Contingent consideration | 23.0 | 95.8 | |||||||||
Total other liabilities, includes $71.7 at June 30, 2023, and $89.1 at December 31, 2022, from consolidated sponsored investment products | 1,330.0 | 1,099.4 | |||||||||
Non-controlling interests* | 1,187.3 | 847.4 | |||||||||
Stockholders' equity attributable to T. Rowe Price Group, Inc., 224.3 common shares outstanding at June 30, 2023 and 224.3 common shares outstanding at December 31, 2022 | $ | 9,263.8 | $ | 8,839.5 |
Three months ended | Six months ended | ||||||||||||||||||||||
Investments in affiliated private investment funds - carried interest | 6/30/2023 | 6/30/2022 | 6/30/2023 | 6/30/2022 | |||||||||||||||||||
Balance at beginning of period | $ | 483.8 | $ | 642.1 | $ | 467.8 | $ | 609.8 | |||||||||||||||
Capital allocation-based income: | |||||||||||||||||||||||
Change in accrued carried interest | 51.0 | (113.0) | 80.2 | (55.4) | |||||||||||||||||||
Acquisition-related amortization | (12.3) | (13.3) | (24.6) | (26.5) | |||||||||||||||||||
Net realized distributions | (8.3) | (8.6) | (9.2) | (20.7) | |||||||||||||||||||
Balance at end of period | $ | 514.2 | $ | 507.2 | $ | 514.2 | $ | 507.2 |
Three months ended | Six months ended | ||||||||||||||||||||||
Non-controlling interests (NCI) in consolidated entities | 6/30/2023 | 6/30/2022 | 6/30/2023 | 6/30/2022 | |||||||||||||||||||
Balance at beginning of period | $ | 194.4 | $ | 272.2 | $ | 190.7 | $ | 248.7 | |||||||||||||||
Capital allocation-based income compensation: | |||||||||||||||||||||||
Change in accrued carried interest compensation | 15.7 | (45.2) | 24.3 | (22.1) | |||||||||||||||||||
Acquisition-related amortization | (5.1) | (5.7) | (10.2) | (11.3) | |||||||||||||||||||
Net distributions | (2.9) | (12.5) | (2.7) | (6.5) | |||||||||||||||||||
Balance at end of period | $ | 202.1 | $ | 208.8 | $ | 202.1 | $ | 208.8 |
Three months ended 6/30/2023 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(6) | Net income attributable to T. Rowe Price | Diluted earnings per share(7) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 1,076.7 | $ | 533.5 | $ | 106.2 | $ | 158.5 | $ | 476.4 | $ | 2.06 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 5.1 | 7.2 | — | 0.1 | 7.1 | 0.03 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (13.6) | 13.6 | — | (0.1) | 13.7 | 0.06 | |||||||||||||||||||||||||||||
Contingent consideration(1) | 23.2 | (23.2) | — | 2.5 | (25.7) | (0.11) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (28.6) | 28.6 | — | 0.4 | 28.2 | 0.12 | |||||||||||||||||||||||||||||
Total acquisition-related non-GAAP adjustments | (13.9) | 26.2 | — | 2.9 | 23.3 | 0.10 | |||||||||||||||||||||||||||||
Supplemental savings plan liability(3) (Compensation and related costs) | (33.0) | 33.0 | (33.6) | 0.2 | (0.8) | — | |||||||||||||||||||||||||||||
Consolidated T. Rowe Price investment products(4) | (3.6) | 3.9 | (24.4) | 0.5 | (16.2) | (0.07) | |||||||||||||||||||||||||||||
Other non-operating income(5) | — | — | (16.4) | (0.2) | (16.2) | (0.07) | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 1,026.2 | $ | 596.6 | $ | 31.8 | $ | 161.9 | $ | 466.5 | $ | 2.02 |
Three months ended 6/30/2022 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(6) | Net income attributable to T. Rowe Price | Diluted earnings per share(7) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 844.4 | $ | 668.6 | $ | (279.9) | $ | 100.9 | $ | 339.6 | $ | 1.46 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 5.7 | 7.6 | — | 2.0 | 5.6 | 0.03 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (18.0) | 18.0 | — | 4.6 | 13.4 | 0.06 | |||||||||||||||||||||||||||||
Contingent consideration(1) | 50.3 | (50.3) | — | (13.5) | (36.8) | (0.16) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (27.2) | 27.2 | — | 7.2 | 20.0 | 0.09 | |||||||||||||||||||||||||||||
Transaction costs(2) (General, admin and other) | (0.1) | 0.1 | — | — | 0.1 | — | |||||||||||||||||||||||||||||
Total acquisition-related non-GAAP adjustments | 10.7 | 2.6 | — | 0.3 | 2.3 | 0.02 | |||||||||||||||||||||||||||||
Supplemental savings plan liability(3) (Compensation and related costs) | 93.5 | (93.5) | 96.4 | 0.6 | 2.3 | — | |||||||||||||||||||||||||||||
Consolidated T. Rowe Price investment products(4) | (1.3) | 2.0 | 104.6 | 14.7 | 40.1 | 0.17 | |||||||||||||||||||||||||||||
Other non-operating income(5) | — | — | 48.3 | 14.9 | 33.4 | 0.14 | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 947.3 | $ | 579.7 | $ | (30.6) | $ | 131.4 | $ | 417.7 | $ | 1.79 |
Three months ended 3/31/2023 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(6) | Net income attributable to T. Rowe Price | Diluted earnings per share(7) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 1,053.4 | $ | 484.2 | $ | 135.4 | $ | 177.9 | $ | 421.5 | $ | 1.83 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 5.1 | 7.2 | — | 1.5 | 5.7 | 0.02 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (14.2) | 14.2 | — | 3.1 | 11.1 | 0.05 | |||||||||||||||||||||||||||||
Contingent consideration(1) | 49.6 | (49.6) | — | (10.5) | (39.1) | (0.17) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (26.0) | 26.0 | — | 5.6 | 20.4 | 0.09 | |||||||||||||||||||||||||||||
Total acquisition-related non-GAAP adjustments | 14.5 | (2.2) | — | (0.3) | (1.9) | (0.01) | |||||||||||||||||||||||||||||
Supplemental savings plan liability(3) (Compensation and related costs) | (42.5) | 42.5 | (44.7) | (0.5) | (1.7) | (0.01) | |||||||||||||||||||||||||||||
Consolidated T. Rowe Price investment products(4) | (2.9) | 3.5 | (45.4) | (4.6) | (17.1) | (0.07) | |||||||||||||||||||||||||||||
Other non-operating income(5) | — | — | (14.5) | (3.1) | (11.4) | (0.05) | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 1,022.5 | $ | 528.0 | $ | 30.8 | $ | 169.4 | $ | 389.4 | $ | 1.69 |
Six months ended 6/30/2023 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(6) | Net income attributable to T. Rowe Price | Diluted earnings per share(7) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 2,130.1 | $ | 1,017.7 | $ | 241.6 | $ | 336.4 | $ | 897.9 | $ | 3.89 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 10.2 | 14.4 | — | 1.6 | 12.8 | 0.06 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (27.8) | 27.8 | — | 3.0 | 24.8 | 0.11 | |||||||||||||||||||||||||||||
Contingent consideration(1) | 72.8 | (72.8) | — | (8.0) | (64.8) | (0.28) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (54.6) | 54.6 | — | 6.0 | 48.6 | 0.21 | |||||||||||||||||||||||||||||
Total acquisition-related non-GAAP adjustments | 0.6 | 24.0 | — | 2.6 | 21.4 | 0.10 | |||||||||||||||||||||||||||||
Supplemental savings plan liability(3) (Compensation and related costs) | (75.5) | 75.5 | (78.3) | (0.3) | (2.5) | (0.01) | |||||||||||||||||||||||||||||
Consolidated T. Rowe Price investment products(4) | (6.5) | 7.4 | (69.8) | (4.1) | (33.3) | (0.14) | |||||||||||||||||||||||||||||
Other non-operating income(5) | — | — | (30.9) | (3.3) | (27.6) | (0.13) | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 2,048.7 | $ | 1,124.6 | $ | 62.6 | $ | 331.3 | $ | 855.9 | $ | 3.71 |
Six months ended 6/30/2022 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(6) | Net income attributable to T. Rowe Price | Diluted earnings per share(7) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 1,830.0 | $ | 1,546.0 | $ | (478.4) | $ | 265.4 | $ | 907.5 | $ | 3.88 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 11.3 | 15.2 | — | 7.3 | 7.9 | 0.04 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (37.2) | 37.2 | — | 10.0 | 27.2 | 0.11 | |||||||||||||||||||||||||||||
Contingent consideration(1) | 95.8 | (95.8) | — | (31.7) | (64.1) | (0.28) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (54.3) | 54.3 | — | 18.0 | 36.3 | 0.16 | |||||||||||||||||||||||||||||
Transaction costs(2) (General, admin and other) | (0.8) | 0.8 | — | 0.3 | 0.5 | — | |||||||||||||||||||||||||||||
Total acquisition-related non-GAAP adjustments | 14.8 | 11.7 | — | 3.9 | 7.8 | 0.03 | |||||||||||||||||||||||||||||
Supplemental savings plan liability(3) (Compensation and related costs) | 144.5 | (144.5) | 151.7 | 2.3 | 4.9 | 0.02 | |||||||||||||||||||||||||||||
Consolidated T. Rowe Price investment products(4) | (2.9) | 4.5 | 206.0 | 35.0 | 70.2 | 0.30 | |||||||||||||||||||||||||||||
Other non-operating income(5) | — | — | 66.3 | 22.1 | 44.2 | 0.19 | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 1,986.4 | $ | 1,417.7 | $ | (54.4) | $ | 328.7 | $ | 1,034.6 | $ | 4.42 |
Three months ended | Six months ended | ||||||||||||||||||||||||||||
6/30/2023 | 6/30/2022 | 3/31/2023 | 6/30/2023 | 6/30/2022 | |||||||||||||||||||||||||
Adjusted net income attributable to T. Rowe Price | $ | 466.5 | $ | 417.7 | $ | 389.4 | $ | 855.9 | $ | 1,034.6 | |||||||||||||||||||
Less: adjusted net income allocated to outstanding restricted stock and stock unit holders | 11.4 | 9.3 | 9.6 | 21.0 | 23.3 | ||||||||||||||||||||||||
Adjusted net income allocated to common stockholders | $ | 455.1 | $ | 408.4 | $ | 379.8 | $ | 834.9 | $ | 1,011.3 |